Resveratrol inhibits phorbol ester-induced membrane translocation of presynaptic Munc13-1

Resveratrol (1) is a naturally occurring polyphenol that has been implicated in neuroprotection. One of resveratrol's several biological targets is Ca2+-sensitive protein kinase C alpha (PKCα). Resveratrol inhibits PKCα by binding to its activator-binding C1 domain. Munc13-1 is a C1 domain-cont...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta Vol. 1861; no. 11; pp. 2640 - 2651
Main Authors Pany, Satyabrata, Ghosh, Anamitra, You, Youngki, Nguyen, Nga, Das, Joydip
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.11.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Resveratrol (1) is a naturally occurring polyphenol that has been implicated in neuroprotection. One of resveratrol's several biological targets is Ca2+-sensitive protein kinase C alpha (PKCα). Resveratrol inhibits PKCα by binding to its activator-binding C1 domain. Munc13-1 is a C1 domain-containing Ca2+-sensitive SNARE complex protein essential for vesicle priming and neurotransmitter release. To test if resveratrol could also bind and inhibit Munc13-1, we studied the interaction of resveratrol and its derivatives, (E)-1,3-dimethoxy-5-(4-methoxystyryl)benzene, (E)-5,5′-(ethene-1,2-diyl)bis(benzene-1,2,3-triol), (E)-1,2-bis(3,4,5-trimethoxyphenyl)ethane, and (E)-5-(4-(hexadecyloxy)-3,5-dihydroxystyryl)benzene-1,2,3-triol with Munc13-1 by studying its membrane translocation from cytosol to plasma membrane in HT22 cells and primary hippocampal neurons. Resveratrol, but not the derivatives inhibited phorbol ester-induced Munc13-1 translocation from cytosol to membrane in HT22 cells and primary hippocampal neurons, as evidenced by immunoblot analysis and confocal microscopy. Resveratrol did not show any effect on Munc13-1H567K, a mutant which is not sensitive to phorbol ester. Binding studies with Munc13-1 C1 indicated that resveratrol competes with phorbol ester for the binding site. Molecular docking and dynamics studies suggested that hydroxyl groups of resveratrol interact with phorbol-ester binding residues in the binding pocket. This study characterizes Munc13-1 as a target of resveratrol and highlights the importance of dietary polyphenol in the management of neurodegenerative diseases. [Display omitted] •Resveratrol binds to the C1 domain of SNARE complex protein Munc13-1•Resveratrol inhibits the activity of Munc13-1 in HT-22 cells and primary hippocampal neurons.•Dietary polyphenols are important in the management of neurodegenerative diseases.
AbstractList Resveratrol (1) is a naturally occurring polyphenol that has been implicated in neuroprotection. One of resveratrol's several biological targets is Ca²⁺-sensitive protein kinase C alpha (PKCα). Resveratrol inhibits PKCα by binding to its activator-binding C1 domain. Munc13-1 is a C1 domain-containing Ca²⁺-sensitive SNARE complex protein essential for vesicle priming and neurotransmitter release.To test if resveratrol could also bind and inhibit Munc13-1, we studied the interaction of resveratrol and its derivatives, (E)-1,3-dimethoxy-5-(4-methoxystyryl)benzene, (E)-5,5′-(ethene-1,2-diyl)bis(benzene-1,2,3-triol), (E)-1,2-bis(3,4,5-trimethoxyphenyl)ethane, and (E)-5-(4-(hexadecyloxy)-3,5-dihydroxystyryl)benzene-1,2,3-triol with Munc13-1 by studying its membrane translocation from cytosol to plasma membrane in HT22 cells and primary hippocampal neurons.Resveratrol, but not the derivatives inhibited phorbol ester-induced Munc13-1 translocation from cytosol to membrane in HT22 cells and primary hippocampal neurons, as evidenced by immunoblot analysis and confocal microscopy. Resveratrol did not show any effect on Munc13-1ᴴ⁵⁶⁷ᴷ, a mutant which is not sensitive to phorbol ester. Binding studies with Munc13-1 C1 indicated that resveratrol competes with phorbol ester for the binding site. Molecular docking and dynamics studies suggested that hydroxyl groups of resveratrol interact with phorbol-ester binding residues in the binding pocket.This study characterizes Munc13-1 as a target of resveratrol and highlights the importance of dietary polyphenol in the management of neurodegenerative diseases.
Resveratrol (1) is a naturally occurring polyphenol that has been implicated in neuroprotection. One of resveratrol's several biological targets is Ca -sensitive protein kinase C alpha (PKCα). Resveratrol inhibits PKCα by binding to its activator-binding C1 domain. Munc13-1 is a C1 domain-containing Ca -sensitive SNARE complex protein essential for vesicle priming and neurotransmitter release. To test if resveratrol could also bind and inhibit Munc13-1, we studied the interaction of resveratrol and its derivatives, (E)-1,3-dimethoxy-5-(4-methoxystyryl)benzene, (E)-5,5'-(ethene-1,2-diyl)bis(benzene-1,2,3-triol), (E)-1,2-bis(3,4,5-trimethoxyphenyl)ethane, and (E)-5-(4-(hexadecyloxy)-3,5-dihydroxystyryl)benzene-1,2,3-triol with Munc13-1 by studying its membrane translocation from cytosol to plasma membrane in HT22 cells and primary hippocampal neurons. Resveratrol, but not the derivatives inhibited phorbol ester-induced Munc13-1 translocation from cytosol to membrane in HT22 cells and primary hippocampal neurons, as evidenced by immunoblot analysis and confocal microscopy. Resveratrol did not show any effect on Munc13-1 , a mutant which is not sensitive to phorbol ester. Binding studies with Munc13-1 C1 indicated that resveratrol competes with phorbol ester for the binding site. Molecular docking and dynamics studies suggested that hydroxyl groups of resveratrol interact with phorbol-ester binding residues in the binding pocket. This study characterizes Munc13-1 as a target of resveratrol and highlights the importance of dietary polyphenol in the management of neurodegenerative diseases.
Resveratrol (1) is a naturally occurring polyphenol that has been implicated in neuroprotection. One of resveratrol's several biological targets is Ca2+-sensitive protein kinase C alpha (PKCα). Resveratrol inhibits PKCα by binding to its activator-binding C1 domain. Munc13-1 is a C1 domain-containing Ca2+-sensitive SNARE complex protein essential for vesicle priming and neurotransmitter release.BACKGROUNDResveratrol (1) is a naturally occurring polyphenol that has been implicated in neuroprotection. One of resveratrol's several biological targets is Ca2+-sensitive protein kinase C alpha (PKCα). Resveratrol inhibits PKCα by binding to its activator-binding C1 domain. Munc13-1 is a C1 domain-containing Ca2+-sensitive SNARE complex protein essential for vesicle priming and neurotransmitter release.To test if resveratrol could also bind and inhibit Munc13-1, we studied the interaction of resveratrol and its derivatives, (E)-1,3-dimethoxy-5-(4-methoxystyryl)benzene, (E)-5,5'-(ethene-1,2-diyl)bis(benzene-1,2,3-triol), (E)-1,2-bis(3,4,5-trimethoxyphenyl)ethane, and (E)-5-(4-(hexadecyloxy)-3,5-dihydroxystyryl)benzene-1,2,3-triol with Munc13-1 by studying its membrane translocation from cytosol to plasma membrane in HT22 cells and primary hippocampal neurons.METHODSTo test if resveratrol could also bind and inhibit Munc13-1, we studied the interaction of resveratrol and its derivatives, (E)-1,3-dimethoxy-5-(4-methoxystyryl)benzene, (E)-5,5'-(ethene-1,2-diyl)bis(benzene-1,2,3-triol), (E)-1,2-bis(3,4,5-trimethoxyphenyl)ethane, and (E)-5-(4-(hexadecyloxy)-3,5-dihydroxystyryl)benzene-1,2,3-triol with Munc13-1 by studying its membrane translocation from cytosol to plasma membrane in HT22 cells and primary hippocampal neurons.Resveratrol, but not the derivatives inhibited phorbol ester-induced Munc13-1 translocation from cytosol to membrane in HT22 cells and primary hippocampal neurons, as evidenced by immunoblot analysis and confocal microscopy. Resveratrol did not show any effect on Munc13-1H567K, a mutant which is not sensitive to phorbol ester. Binding studies with Munc13-1 C1 indicated that resveratrol competes with phorbol ester for the binding site. Molecular docking and dynamics studies suggested that hydroxyl groups of resveratrol interact with phorbol-ester binding residues in the binding pocket.RESULTSResveratrol, but not the derivatives inhibited phorbol ester-induced Munc13-1 translocation from cytosol to membrane in HT22 cells and primary hippocampal neurons, as evidenced by immunoblot analysis and confocal microscopy. Resveratrol did not show any effect on Munc13-1H567K, a mutant which is not sensitive to phorbol ester. Binding studies with Munc13-1 C1 indicated that resveratrol competes with phorbol ester for the binding site. Molecular docking and dynamics studies suggested that hydroxyl groups of resveratrol interact with phorbol-ester binding residues in the binding pocket.This study characterizes Munc13-1 as a target of resveratrol and highlights the importance of dietary polyphenol in the management of neurodegenerative diseases.CONCLUSIONS AND SIGNIFICANCEThis study characterizes Munc13-1 as a target of resveratrol and highlights the importance of dietary polyphenol in the management of neurodegenerative diseases.
Resveratrol (1) is a naturally occurring polyphenol that has been implicated in neuroprotection. One of resveratrol's several biological targets is Ca2+-sensitive protein kinase C alpha (PKCα). Resveratrol inhibits PKCα by binding to its activator-binding C1 domain. Munc13-1 is a C1 domain-containing Ca2+-sensitive SNARE complex protein essential for vesicle priming and neurotransmitter release. To test if resveratrol could also bind and inhibit Munc13-1, we studied the interaction of resveratrol and its derivatives, (E)-1,3-dimethoxy-5-(4-methoxystyryl)benzene, (E)-5,5′-(ethene-1,2-diyl)bis(benzene-1,2,3-triol), (E)-1,2-bis(3,4,5-trimethoxyphenyl)ethane, and (E)-5-(4-(hexadecyloxy)-3,5-dihydroxystyryl)benzene-1,2,3-triol with Munc13-1 by studying its membrane translocation from cytosol to plasma membrane in HT22 cells and primary hippocampal neurons. Resveratrol, but not the derivatives inhibited phorbol ester-induced Munc13-1 translocation from cytosol to membrane in HT22 cells and primary hippocampal neurons, as evidenced by immunoblot analysis and confocal microscopy. Resveratrol did not show any effect on Munc13-1H567K, a mutant which is not sensitive to phorbol ester. Binding studies with Munc13-1 C1 indicated that resveratrol competes with phorbol ester for the binding site. Molecular docking and dynamics studies suggested that hydroxyl groups of resveratrol interact with phorbol-ester binding residues in the binding pocket. This study characterizes Munc13-1 as a target of resveratrol and highlights the importance of dietary polyphenol in the management of neurodegenerative diseases. [Display omitted] •Resveratrol binds to the C1 domain of SNARE complex protein Munc13-1•Resveratrol inhibits the activity of Munc13-1 in HT-22 cells and primary hippocampal neurons.•Dietary polyphenols are important in the management of neurodegenerative diseases.
Author Nguyen, Nga
Ghosh, Anamitra
Pany, Satyabrata
You, Youngki
Das, Joydip
Author_xml – sequence: 1
  givenname: Satyabrata
  surname: Pany
  fullname: Pany, Satyabrata
– sequence: 2
  givenname: Anamitra
  surname: Ghosh
  fullname: Ghosh, Anamitra
– sequence: 3
  givenname: Youngki
  surname: You
  fullname: You, Youngki
– sequence: 4
  givenname: Nga
  surname: Nguyen
  fullname: Nguyen, Nga
– sequence: 5
  givenname: Joydip
  surname: Das
  fullname: Das, Joydip
  email: jdas@uh.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28713022$$D View this record in MEDLINE/PubMed
BookMark eNqFUU1r3DAQFSWh2aT9B6X42Is3-rBlu4dCCekHJBRKe-hJ6GOc1WJLrmQv5N930t2UJodEDJKYefN4M--UHIUYgJA3jK4ZZfJ8uzZG30BYc8qaNcWg8gVZsbbhZYv_I7KiglZlxWR9Qk5z3lI8dVe_JCe8bZignK_Ir--Qd5D0nOJQ-LDxxs-5mDYxGUxAniGVPrjFgitGGE3SAYoZ7zxEq2cfQxH7YkqQb4OeZm-L6yVYJkr2ihz3esjw-vCekZ-fLn9cfCmvvn3-evHxqrRVJ-dStryvdQN9Y5yuTe8aTLRUgNGdEU4LhnXXQMe72kjHhan7XpqWas6rCrQ4Ix_2vNNiRnAWAsob1JT8qNOtitqrh5XgN-om7lQtuZC8QoJ3B4IUfy84shp9tjAMOGpcsuK4tkoK0T0PZR2a0ck99O3_sv7puV89At7vATbFnBP0yvr570ZRpR8Uo-rOZ7VVe5_Vnc-KYlCJzdWj5nv-Z9oOuwI0ZOchqWw9BDTXJ7CzctE_TfAHP_PF5A
CitedBy_id crossref_primary_10_1021_acs_biochem_9b00427
crossref_primary_10_1021_acs_biochem_3c00375
crossref_primary_10_1016_j_neuroscience_2022_02_008
crossref_primary_10_3390_cells9030553
crossref_primary_10_2174_1568026619666190301173958
crossref_primary_10_1080_07391102_2021_2001375
crossref_primary_10_1021_acs_biochem_1c00165
crossref_primary_10_1021_acs_jafc_1c03699
crossref_primary_10_1002_2211_5463_13488
Cites_doi 10.1016/j.bbadis.2014.10.005
10.1038/14764
10.1016/0092-8674(95)90011-X
10.1021/acs.biochem.6b00932
10.1002/prot.21123
10.1038/12160
10.1002/mnfr.200800177
10.7554/eLife.22567
10.1038/nsmb1001
10.1007/s12035-010-8111-y
10.1016/j.neurobiolaging.2011.10.029
10.1016/S0959-4388(00)00105-7
10.1371/journal.pone.0052888
10.1016/j.bbagen.2015.07.005
10.2174/156720209787466019
10.1111/j.1749-6632.2010.05857.x
10.1186/1756-0500-5-367
10.1155/2015/392169
10.2337/db05-1263
10.1021/ct700301q
10.1172/JCI90259
10.1074/jbc.270.18.10777
10.1042/BJ20082271
10.1021/bi0476127
10.3389/fnagi.2014.00218
10.1016/j.ejmg.2014.01.002
10.1016/S0925-4439(02)00214-4
10.1523/JNEUROSCI.19-12-04772.1999
10.1016/j.neuron.2013.05.011
10.1111/nyas.12796
10.1074/jbc.C400122200
10.1016/S0149-7634(98)00039-6
10.1016/j.bmc.2011.08.008
10.1021/cr300481j
10.1096/fj.03-0168rev
10.1111/j.1749-6632.2010.05865.x
10.1038/nprot.2006.356
10.1042/bj3370363
10.1038/ncomms8319
10.1186/s12951-016-0177-x
10.1007/BF01531994
10.1111/j.1749-6632.2010.05842.x
10.1523/JNEUROSCI.5128-12.2013
10.2174/187152710793237494
10.1523/JNEUROSCI.20-02-00666.2000
10.1002/mus.24198
10.1038/22768
10.1074/jbc.272.4.2520
10.1523/JNEUROSCI.2276-11.2011
10.1063/1.470117
10.1002/iub.47
10.3233/JAD-132621
10.1016/S0896-6273(02)00568-8
10.1111/jnc.12315
10.1002/ana.24198
10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
10.1186/1750-1326-2-23
10.1074/jbc.272.26.16081
10.1021/jf010812u
10.1021/acs.biochem.6b00057
10.3389/fendo.2013.00119
10.1016/S0031-9422(03)00417-5
10.1038/nsmb.2047
10.1074/jbc.M306749200
10.1016/j.ijdevneu.2012.10.001
10.1073/pnas.122623799
10.1074/jbc.M601421200
10.1523/JNEUROSCI.4908-06.2007
10.1089/ars.2008.2412
10.3945/jn.110.123505
10.1016/S0896-6273(00)80520-6
10.1016/j.bbadis.2014.09.011
10.1016/j.ijdevneu.2004.07.004
10.1007/s13311-014-0334-6
10.1111/nyas.12130
ContentType Journal Article
Copyright 2017 Elsevier B.V.
Copyright © 2017 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2017 Elsevier B.V.
– notice: Copyright © 2017 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
5PM
DOI 10.1016/j.bbagen.2017.07.006
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1872-8006
1878-2434
EndPage 2651
ExternalDocumentID PMC5623624
28713022
10_1016_j_bbagen_2017_07_006
S0304416517302179
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAAA NIH HHS
  grantid: R01 AA022414
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
7X8
7S9
L.6
-~X
5PM
ABJNI
F5P
TWZ
Y6R
ID FETCH-LOGICAL-c496t-682f5a7ef7bda5bfd782f803eba9b3da312f5d7e9295b6d23b5ff6b80a2244ea3
IEDL.DBID .~1
ISSN 0304-4165
0006-3002
IngestDate Thu Aug 21 18:24:04 EDT 2025
Fri Jul 11 03:09:57 EDT 2025
Tue Aug 05 10:36:28 EDT 2025
Mon Jul 21 05:42:29 EDT 2025
Thu Apr 24 22:57:19 EDT 2025
Tue Jul 01 00:22:09 EDT 2025
Fri Feb 23 02:32:41 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords Neuroprotection
Protein kinase C
BBB
PS
TPA
DMSO
HRP
PFA
Activation
EGFP
MTT
Membrane translocation
SNARE
DMEM
FITC
Polyphenol
FBS
MD
Resveratrol
FRET
Inhibition
Presynaptic
AD
DPPH
MALDI-TOF
GST
PKC
DAG
SDS-PAGE
Munc13-1
PEI
IPTG
Language English
License Copyright © 2017 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c496t-682f5a7ef7bda5bfd782f803eba9b3da312f5d7e9295b6d23b5ff6b80a2244ea3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/5623624
PMID 28713022
PQID 1920196394
PQPubID 23479
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5623624
proquest_miscellaneous_2000463394
proquest_miscellaneous_1920196394
pubmed_primary_28713022
crossref_citationtrail_10_1016_j_bbagen_2017_07_006
crossref_primary_10_1016_j_bbagen_2017_07_006
elsevier_sciencedirect_doi_10_1016_j_bbagen_2017_07_006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-11-01
PublicationDateYYYYMMDD 2017-11-01
PublicationDate_xml – month: 11
  year: 2017
  text: 2017-11-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biochimica et biophysica acta
PublicationTitleAlternate Biochim Biophys Acta Gen Subj
PublicationYear 2017
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Myhrer (bb0345) 1998; 23
Kazanietz, Lewin, Bruns, Blumberg (bb0220) 1995; 270
Sun, Wang, Simonyi, Sun (bb0025) 2010; 41
Seibenhener, Wooten (bb0270) 2012; 65
Hess, Kutzner, van der Spoel, Lindahl (bb0280) 2008; 4
Andrews-Zwilling, Kawabe, Reim, Varoqueaux, Brose (bb0210) 2006; 281
Pany, Majhi, Das (bb0070) 2012; 7
Lipstein, Sakaba, Cooper, Lin, Strenzke, Ashery, Rhee, Taschenberger, Neher, Brose (bb0110) 2013; 79
Pirola, Frojdo (bb0055) 2008; 60
Rosenmund, Sigler, Augustin, Reim, Brose, Rhee (bb0105) 2002; 33
Essmann, Perera, Berkowitz, Darden, Lee, Pedersen (bb0305) 1995; 103
Friedrich, Gottfried, Ashery (bb0320) 2013; 4
Diekstra, van Vught, van Rheenen, Koppers, Pasterkamp, van Es, Schelhaas, de Visser, Robberecht, Van Damme, Andersen, van den Berg, Veldink (bb0190) 2012; 33
Hess, Bekker, Berendsen, Fraaije (bb0300) 1997; 18
Tellone, Galtieri, Russo, Giardina, Ficarra (bb0030) 2015; 2015
Pirola, Fröjdö (bb0040) 2008; 60
Augustin, Andrea, HERRMANN, Tobias, BROSE (bb0100) 1999; 337
Lipstein, Verhoeven-Duif, Michelassi, Calloway, van Hasselt, Pienkowska, van Haaften, van Haelst, van Empelen, Cuppen, van Teeseling, Evelein, Vorstman, Thoms, Jahn, Duran, Monroe, Ryan, Taschenberger, Dittman, Rhee, Visser, Jans, Brose (bb0145) 2017
Almeida, Vaz-da-Silva, Falcão, Soares, Costa, Loureiro, Fernandes-Lopes, Rocha, Nunes, Wright (bb0360) 2009; 53
Augustin, Rosenmund, Sudhof, Brose (bb0125) 1999; 400
Xu, Camacho, Xu, Esser, Liu, Trimbuch, Pan, Ma, Tomchick, Rosenmund (bb0325) 2017; 6
Britton, Kovoor, Brown (bb0045) 2015; 1348
Aravamudan, Fergestad, Davis, Rodesch, Broadie (bb0135) 1999; 2
Rossner, Fuchsbrunner, Lange-Dohna, Hartlage-Rubsamen, Bigl, Betz, Reim, Brose (bb0155) 2004; 279
Brose, Rosenmund, Rettig (bb0090) 2000; 10
Veriepe, Fossouo, Parker (bb0195) 2015; 6
Gambini, Inglés, Olaso, Lopez-Grueso, Bonet-Costa, Gimeno-Mallench, Mas-Bargues, Abdelaziz, Gomez-Cabrera, Vina (bb0370) 2015; 837042
Varoqueaux, Sigler, Rhee, Brose, Enk, Reim, Rosenmund (bb0130) 2002; 99
Hartlage-Rubsamen, Waniek, Rossner (bb0165) 2013; 31
Pervaiz, Holme (bb0050) 2009; 11
Diekstra, Van Deerlin, van Swieten, Al-Chalabi, Ludolph, Weishaupt, Hardiman, Landers, Brown, van Es, Pasterkamp, Koppers, Andersen, Estrada, Rivadeneira, Hofman, Uitterlinden, van Damme, Melki, Meininger, Shatunov, Shaw, Leigh, Shaw, Morrison, Fogh, Chio, Traynor, Czell, Weber, Heutink, de Bakker, Silani, Robberecht, van den Berg, Veldink (bb0185) 2014; 76
Rege, Geetha, Griffin, Broderick, Babu (bb0020) 2014; 6
Kulkarni, Cantó (bb0035) 2015; 1852
Piontek, Brandt (bb0255) 2003; 278
Richard, Pawlus, Iglesias, Pedrot, Waffo-Teguo, Merillon, Monti (bb0015) 2011; 1215
Pervaiz (bb0005) 2003; 17
Wang, Catana, Yang, Roderick, van Breemen (bb0010) 2002; 50
Slater, Seiz, Cook, Stagliano, Buzas (bb0065) 2003; 1637
Walle (bb0365) 2011; 1215
Augustin, Sanguansri, Lockett (bb0385) 2013; 1290
Betz, Okamoto, Benseler, Brose (bb0075) 1997; 272
Kwan, Xie, Sheu, Nolan, Prentki, Betz, Brose, Gaisano (bb0120) 2006; 55
Basu, Betz, Brose, Rosenmund (bb0225) 2007; 27
Yang, Calakos (bb0115) 2011; 31
Ikin, Causevic, Pedrini, Benson, Buxbaum, Suzuki, Lovestone, Higashiyama, Mustelin, Burgoyne, Gandy (bb0160) 2007; 2
Sousa da Silva, Vranken (bb0290) 2012; 5
Das, Pany, Majhi (bb0060) 2011; 19
Lee, Min, An, Na, Lee, Lee, Kim, Bae, Kang (bb0310) 2003; 64
Pany, You, Das (bb0260) 2016; 55
Bosco, Landers (bb0170) 2010; 9
Zadori, Veres, Szalardy, Klivenyi, Toldi, Vecsei (bb0350) 2014; 42
Berendsen (bb0295) 1988; 2
Kaech, Banker (bb0265) 2006; 1
Bastianetto, Menard, Quirion (bb0335) 2015; 1852
Chen, Cooper, Kalla, Varoqueaux, Young (bb0095) 2013; 33
Su, Broach, Connor, Gerhard, Simmons (bb0175) 2014; 49
Finsterer, Burgunder (bb0180) 2014; 57
Shen, Guryev, Rizo (bb0230) 2005; 44
Lin, Chang, Chen, Chang, Chiu, Lin, Chen (bb0375) 2010; 140
Neves, Queiroz, Reis (bb0390) 2016; 14
Shu, Wang, Li, Song, Shi, Gu, Wu, Chen, Kong, Liu (bb0380) 2015; 12
Das, Pany, Rahman, Slater (bb0275) 2009; 421
Zhang, Kazanietz, Blumberg, Hurley (bb0235) 1995; 81
Pallàs, Casadesús, Smith, Coto-Montes, Pelegri, Vilaplana, Camins (bb0330) 2009; 6
Sassa, Harada, Ogawa, Rand, Maruyama, Hosono (bb0080) 1999; 19
Das, Rahman (bb0215) 2014; 114
Pany, Majhi, Das (bb0240) 2016; 55
Quincozes-Santos, Gottfried (bb0340) 2011; 1215
Betz, Ashery, Rickmann, Augustin, Neher, Sudhof, Rettig, Brose (bb0085) 1998; 21
Araque, Li, Doyle, Haydon (bb0355) 2000; 20
Ma, Li, Xu, Rizo (bb0200) 2011; 18
Hornak, Abel, Okur, Strockbine, Roitberg, Simmerling (bb0285) 2006; 65
Rossner (bb0150) 2004; 22
Pany, Das (bb0250) 2015; 1850
Richmond, Davis, Jorgensen (bb0140) 1999; 2
Das, Xu, Pany, Guillory, Shah, Roman (bb0245) 2013; 126
Basu, Shen, Dulubova, Lu, Guan, Guryev, Grishin, Rosenmund, Rizo (bb0205) 2005; 12
Orita, Naito, Sakaguchi, Maeda, Igarashi, Sasaki, Takai (bb0315) 1997; 272
Hess (10.1016/j.bbagen.2017.07.006_bb0280) 2008; 4
Hartlage-Rubsamen (10.1016/j.bbagen.2017.07.006_bb0165) 2013; 31
Lee (10.1016/j.bbagen.2017.07.006_bb0310) 2003; 64
Orita (10.1016/j.bbagen.2017.07.006_bb0315) 1997; 272
Almeida (10.1016/j.bbagen.2017.07.006_bb0360) 2009; 53
Chen (10.1016/j.bbagen.2017.07.006_bb0095) 2013; 33
Das (10.1016/j.bbagen.2017.07.006_bb0060) 2011; 19
Walle (10.1016/j.bbagen.2017.07.006_bb0365) 2011; 1215
Rossner (10.1016/j.bbagen.2017.07.006_bb0150) 2004; 22
Diekstra (10.1016/j.bbagen.2017.07.006_bb0190) 2012; 33
Ma (10.1016/j.bbagen.2017.07.006_bb0200) 2011; 18
Xu (10.1016/j.bbagen.2017.07.006_bb0325) 2017; 6
Das (10.1016/j.bbagen.2017.07.006_bb0275) 2009; 421
Kulkarni (10.1016/j.bbagen.2017.07.006_bb0035) 2015; 1852
Rosenmund (10.1016/j.bbagen.2017.07.006_bb0105) 2002; 33
Shen (10.1016/j.bbagen.2017.07.006_bb0230) 2005; 44
Su (10.1016/j.bbagen.2017.07.006_bb0175) 2014; 49
Zadori (10.1016/j.bbagen.2017.07.006_bb0350) 2014; 42
Diekstra (10.1016/j.bbagen.2017.07.006_bb0185) 2014; 76
Bastianetto (10.1016/j.bbagen.2017.07.006_bb0335) 2015; 1852
Slater (10.1016/j.bbagen.2017.07.006_bb0065) 2003; 1637
Pirola (10.1016/j.bbagen.2017.07.006_bb0055) 2008; 60
Kaech (10.1016/j.bbagen.2017.07.006_bb0265) 2006; 1
Lipstein (10.1016/j.bbagen.2017.07.006_bb0110) 2013; 79
Kazanietz (10.1016/j.bbagen.2017.07.006_bb0220) 1995; 270
Pany (10.1016/j.bbagen.2017.07.006_bb0070) 2012; 7
Sassa (10.1016/j.bbagen.2017.07.006_bb0080) 1999; 19
Augustin (10.1016/j.bbagen.2017.07.006_bb0385) 2013; 1290
Friedrich (10.1016/j.bbagen.2017.07.006_bb0320) 2013; 4
Hornak (10.1016/j.bbagen.2017.07.006_bb0285) 2006; 65
Augustin (10.1016/j.bbagen.2017.07.006_bb0125) 1999; 400
Richmond (10.1016/j.bbagen.2017.07.006_bb0140) 1999; 2
Das (10.1016/j.bbagen.2017.07.006_bb0245) 2013; 126
Pany (10.1016/j.bbagen.2017.07.006_bb0250) 2015; 1850
Quincozes-Santos (10.1016/j.bbagen.2017.07.006_bb0340) 2011; 1215
Sousa da Silva (10.1016/j.bbagen.2017.07.006_bb0290) 2012; 5
Yang (10.1016/j.bbagen.2017.07.006_bb0115) 2011; 31
Pervaiz (10.1016/j.bbagen.2017.07.006_bb0050) 2009; 11
Hess (10.1016/j.bbagen.2017.07.006_bb0300) 1997; 18
Sun (10.1016/j.bbagen.2017.07.006_bb0025) 2010; 41
Berendsen (10.1016/j.bbagen.2017.07.006_bb0295) 1988; 2
Pervaiz (10.1016/j.bbagen.2017.07.006_bb0005) 2003; 17
Araque (10.1016/j.bbagen.2017.07.006_bb0355) 2000; 20
Rossner (10.1016/j.bbagen.2017.07.006_bb0155) 2004; 279
Neves (10.1016/j.bbagen.2017.07.006_bb0390) 2016; 14
Betz (10.1016/j.bbagen.2017.07.006_bb0085) 1998; 21
Pany (10.1016/j.bbagen.2017.07.006_bb0260) 2016; 55
Gambini (10.1016/j.bbagen.2017.07.006_bb0370) 2015; 837042
Rege (10.1016/j.bbagen.2017.07.006_bb0020) 2014; 6
Basu (10.1016/j.bbagen.2017.07.006_bb0225) 2007; 27
Wang (10.1016/j.bbagen.2017.07.006_bb0010) 2002; 50
Richard (10.1016/j.bbagen.2017.07.006_bb0015) 2011; 1215
Essmann (10.1016/j.bbagen.2017.07.006_bb0305) 1995; 103
Andrews-Zwilling (10.1016/j.bbagen.2017.07.006_bb0210) 2006; 281
Zhang (10.1016/j.bbagen.2017.07.006_bb0235) 1995; 81
Pallàs (10.1016/j.bbagen.2017.07.006_bb0330) 2009; 6
Aravamudan (10.1016/j.bbagen.2017.07.006_bb0135) 1999; 2
Lipstein (10.1016/j.bbagen.2017.07.006_bb0145) 2017
Seibenhener (10.1016/j.bbagen.2017.07.006_bb0270) 2012; 65
Veriepe (10.1016/j.bbagen.2017.07.006_bb0195) 2015; 6
Shu (10.1016/j.bbagen.2017.07.006_bb0380) 2015; 12
Tellone (10.1016/j.bbagen.2017.07.006_bb0030) 2015; 2015
Betz (10.1016/j.bbagen.2017.07.006_bb0075) 1997; 272
Bosco (10.1016/j.bbagen.2017.07.006_bb0170) 2010; 9
Das (10.1016/j.bbagen.2017.07.006_bb0215) 2014; 114
Pirola (10.1016/j.bbagen.2017.07.006_bb0040) 2008; 60
Finsterer (10.1016/j.bbagen.2017.07.006_bb0180) 2014; 57
Myhrer (10.1016/j.bbagen.2017.07.006_bb0345) 1998; 23
Ikin (10.1016/j.bbagen.2017.07.006_bb0160) 2007; 2
Kwan (10.1016/j.bbagen.2017.07.006_bb0120) 2006; 55
Piontek (10.1016/j.bbagen.2017.07.006_bb0255) 2003; 278
Pany (10.1016/j.bbagen.2017.07.006_bb0240) 2016; 55
Augustin (10.1016/j.bbagen.2017.07.006_bb0100) 1999; 337
Britton (10.1016/j.bbagen.2017.07.006_bb0045) 2015; 1348
Varoqueaux (10.1016/j.bbagen.2017.07.006_bb0130) 2002; 99
Basu (10.1016/j.bbagen.2017.07.006_bb0205) 2005; 12
Lin (10.1016/j.bbagen.2017.07.006_bb0375) 2010; 140
Brose (10.1016/j.bbagen.2017.07.006_bb0090) 2000; 10
11832228 - Neuron. 2002 Jan 31;33(3):411-24
11804508 - J Agric Food Chem. 2002 Jan 30;50(3):431-5
21261636 - Ann N Y Acad Sci. 2011 Jan;1215:9-15
28192369 - J Clin Invest. 2017 Mar 1;127(3):1005-1018
16704978 - J Biol Chem. 2006 Jul 14;281(28):19720-31
22824207 - BMC Res Notes. 2012 Jul 23;5:367
26059317 - Nat Commun. 2015 Jun 10;6:7319
21499244 - Nat Struct Mol Biol. 2011 May;18(5):542-9
26983836 - Biochemistry. 2016 Apr 12;55(14):2135-43
19355928 - Curr Neurovasc Res. 2009 Feb;6(1):70-81
8999968 - J Biol Chem. 1997 Jan 24;272(4):2520-6
21880495 - Bioorg Med Chem. 2011 Sep 15;19(18):5321-33
25375355 - Chem Rev. 2014 Dec 24;114(24):12108-31
3236048 - J Comput Aided Mol Des. 1988 Oct;2(3):217-21
23692447 - J Neurochem. 2013 Sep;126(6):715-26
27776404 - Biochemistry. 2016 Nov 15;55(45):6327-6336
16228007 - Nat Struct Mol Biol. 2005 Nov;12(11):1017-8
17406484 - Nat Protoc. 2006;1(5):2406-15
19432558 - Biochem J. 2009 Jul 15;421(3):405-13
24062723 - Front Endocrinol (Lausanne). 2013 Sep 17;4:119
15465276 - Int J Dev Neurosci. 2004 Nov;22(7):467-74
23658173 - J Neurosci. 2013 May 8;33(19):8336-51
19432534 - Antioxid Redox Signal. 2009 Nov;11(11):2851-97
12857743 - J Biol Chem. 2003 Oct 3;278(40):38970-9
26180587 - Oxid Med Cell Longev. 2015;2015:392169
16981200 - Proteins. 2006 Nov 15;65(3):712-25
25281824 - Biochim Biophys Acta. 2015 Jun;1852(6):1195-201
25309423 - Front Aging Neurosci. 2014 Sep 11;6:218
20980646 - J Nutr. 2010 Dec;140(12):2187-92
23285216 - PLoS One. 2012;7(12):e52888
9861617 - Neurosci Biobehav Rev. 1998;23(1):131-9
22871921 - J Vis Exp. 2012 Jul 26;(65):null
24503148 - Eur J Med Genet. 2014 Feb;57(2-3):103-12
25588581 - Neurotherapeutics. 2015 Apr;12(2):491-501
26210390 - Biochim Biophys Acta. 2015 Nov;1850(11):2368-76
16644700 - Diabetes. 2006 May;55(5):1421-9
23070049 - Int J Dev Neurosci. 2013 Feb;31(1):36-45
24670398 - J Alzheimers Dis. 2014;42 Suppl 3:S177-87
23855472 - Ann N Y Acad Sci. 2013 Jul;1290:107-12
26099829 - Ann N Y Acad Sci. 2015 Aug;1348(1):124-33
22118904 - Neurobiol Aging. 2012 Mar;33(3):630.e3-8
17267576 - J Neurosci. 2007 Jan 31;27(5):1200-10
9895278 - Biochem J. 1999 Feb 1;337 ( Pt 3):363-71
21261643 - Ann N Y Acad Sci. 2011 Jan;1215:72-8
20306310 - Mol Neurobiol. 2010 Jun;41(2-3):375-83
10632596 - J Neurosci. 2000 Jan 15;20(2):666-73
28177287 - Elife. 2017 Feb 08;6:null
15123597 - J Biol Chem. 2004 Jul 2;279(27):27841-4
10366611 - J Neurosci. 1999 Jun 15;19(12):4772-7
10526333 - Nat Neurosci. 1999 Nov;2(11):959-64
23770256 - Neuron. 2013 Jul 10;79(1):82-96
14597667 - FASEB J. 2003 Nov;17(14):1975-85
7781068 - Cell. 1995 Jun 16;81(6):917-24
26221416 - Oxid Med Cell Longev. 2015;2015:837042
18421779 - IUBMB Life. 2008 May;60(5):323-32
7537738 - J Biol Chem. 1995 May 5;270(18):10777-83
15667202 - Biochemistry. 2005 Feb 1;44(4):1089-96
21261647 - Ann N Y Acad Sci. 2011 Jan;1215:103-8
12070347 - Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):9037-42
24488689 - Muscle Nerve. 2014 Jun;49(6):786-803
9195900 - J Biol Chem. 1997 Jun 27;272(26):16081-4
13679099 - Phytochemistry. 2003 Oct;64(3):759-63
19194969 - Mol Nutr Food Res. 2009 May;53 Suppl 1:S7-15
27061902 - J Nanobiotechnology. 2016 Apr 09;14 :27
10526334 - Nat Neurosci. 1999 Nov;2(11):965-71
18067682 - Mol Neurodegener. 2007 Dec 09;2:23
20942785 - CNS Neurol Disord Drug Targets. 2010 Dec;9(6):779-90
10440375 - Nature. 1999 Jul 29;400(6743):457-61
12527408 - Biochim Biophys Acta. 2003 Jan 20;1637(1):59-69
10851170 - Curr Opin Neurobiol. 2000 Jun;10(3):303-11
24931836 - Ann Neurol. 2014 Jul;76(1):120-33
25315298 - Biochim Biophys Acta. 2015 Jun;1852(6):1114-23
21849565 - J Neurosci. 2011 Aug 17;31(33):12053-7
9697857 - Neuron. 1998 Jul;21(1):123-36
26620784 - J Chem Theory Comput. 2008 Mar;4(3):435-47
References_xml – volume: 55
  start-page: 1421
  year: 2006
  end-page: 1429
  ident: bb0120
  article-title: Munc13-1 deficiency reduces insulin secretion and causes abnormal glucose tolerance
  publication-title: Diabetes
– volume: 6
  year: 2017
  ident: bb0325
  article-title: Mechanistic insights into neurotransmitter release and presynaptic plasticity from the crystal structure of Munc13-1 C1C2BMUN
  publication-title: elife
– volume: 33
  start-page: 411
  year: 2002
  end-page: 424
  ident: bb0105
  article-title: Differential control of vesicle priming and short-term plasticity by Munc13 isoforms
  publication-title: Neuron
– volume: 31
  start-page: 12053
  year: 2011
  end-page: 12057
  ident: bb0115
  article-title: Munc13-1 is required for presynaptic long-term potentiation
  publication-title: J. Neurosci.
– volume: 49
  start-page: 786
  year: 2014
  end-page: 803
  ident: bb0175
  article-title: Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research
  publication-title: Muscle Nerve
– volume: 11
  start-page: 2851
  year: 2009
  end-page: 2897
  ident: bb0050
  article-title: Resveratrol: its biologic targets and functional activity
  publication-title: Antioxid. Redox Signal.
– volume: 57
  start-page: 103
  year: 2014
  end-page: 112
  ident: bb0180
  article-title: Recent progress in the genetics of motor neuron disease
  publication-title: Eur. J. Med. Genet.
– volume: 18
  start-page: 542
  year: 2011
  end-page: 549
  ident: bb0200
  article-title: Munc13 mediates the transition from the closed syntaxin-Munc18 complex to the SNARE complex
  publication-title: Nat. Struct. Mol. Biol.
– volume: 4
  start-page: 119
  year: 2013
  ident: bb0320
  article-title: Munc13-1 translocates to the plasma membrane in a Doc2B- and calcium-dependent manner
  publication-title: Front. Endocrinol.
– volume: 55
  start-page: 2135
  year: 2016
  end-page: 2143
  ident: bb0240
  article-title: Selective modulation of protein kinase C alpha over protein kinase C epsilon by curcumin and its derivatives in CHO-K1 Cells
  publication-title: Biochemistry
– volume: 12
  start-page: 1017
  year: 2005
  ident: bb0205
  article-title: A minimal domain responsible for Munc13 activity
  publication-title: Nat. Struct. Mol. Biol.
– volume: 79
  start-page: 82
  year: 2013
  end-page: 96
  ident: bb0110
  article-title: Dynamic control of synaptic vesicle replenishment and short-term plasticity by Ca(2
  publication-title: Neuron
– volume: 103
  start-page: 8577
  year: 1995
  end-page: 8593
  ident: bb0305
  article-title: A Smooth particle mesh ewald method
  publication-title: J. Chem. Phys.
– volume: 42
  start-page: S177
  year: 2014
  end-page: 187
  ident: bb0350
  article-title: Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets
  publication-title: J. Alzheimers Dis.
– volume: 21
  start-page: 123
  year: 1998
  end-page: 136
  ident: bb0085
  article-title: Munc13-1 is a presynaptic phorbol ester receptor that enhances neurotransmitter release
  publication-title: Neuron
– volume: 23
  start-page: 131
  year: 1998
  end-page: 139
  ident: bb0345
  article-title: Adverse psychological impact, glutamatergic dysfunction, and risk factors for Alzheimer's disease
  publication-title: Neurosci. Biobehav. Rev.
– volume: 65
  start-page: 712
  year: 2006
  end-page: 725
  ident: bb0285
  article-title: Comparison of multiple amber force fields and development of improved protein backbone parameters
  publication-title: Proteins
– volume: 1215
  start-page: 72
  year: 2011
  end-page: 78
  ident: bb0340
  article-title: Resveratrol modulates astroglial functions: neuroprotective hypothesis
  publication-title: Ann. N. Y. Acad. Sci.
– volume: 64
  start-page: 759
  year: 2003
  end-page: 763
  ident: bb0310
  article-title: Stilbenes from the roots of
  publication-title: Phytochemistry
– volume: 17
  start-page: 1975
  year: 2003
  end-page: 1985
  ident: bb0005
  article-title: Resveratrol: from grapevines to mammalian biology
  publication-title: FASEB J.
– year: 2017
  ident: bb0145
  article-title: Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder
  publication-title: J. Clin. Invest.
– volume: 1348
  start-page: 124
  year: 2015
  end-page: 133
  ident: bb0045
  article-title: Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms
  publication-title: Ann. N. Y. Acad. Sci.
– volume: 4
  start-page: 435
  year: 2008
  end-page: 447
  ident: bb0280
  article-title: GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation
  publication-title: J. Chem. Theory Comput.
– volume: 50
  start-page: 431
  year: 2002
  end-page: 435
  ident: bb0010
  article-title: An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine
  publication-title: J. Agric. Food Chem.
– volume: 60
  start-page: 323
  year: 2008
  end-page: 332
  ident: bb0055
  article-title: Resveratrol: one molecule, many targets
  publication-title: IUBMB Life
– volume: 1
  start-page: 2406
  year: 2006
  end-page: 2415
  ident: bb0265
  article-title: Culturing hippocampal neurons
  publication-title: Nat. Protoc.
– volume: 22
  start-page: 467
  year: 2004
  end-page: 474
  ident: bb0150
  article-title: New players in old amyloid precursor protein-processing pathways
  publication-title: Int. J. Dev. Neurosci.
– volume: 27
  start-page: 1200
  year: 2007
  end-page: 1210
  ident: bb0225
  article-title: Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion
  publication-title: J. Neurosci.
– volume: 53
  start-page: S7
  year: 2009
  end-page: S15
  ident: bb0360
  article-title: Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
  publication-title: Mol. Nutr. Food Res.
– volume: 60
  start-page: 323
  year: 2008
  end-page: 332
  ident: bb0040
  article-title: Resveratrol: one molecule, many targets
  publication-title: IUBMB Life
– volume: 20
  start-page: 666
  year: 2000
  end-page: 673
  ident: bb0355
  article-title: SNARE protein-dependent glutamate release from astrocytes
  publication-title: J. Neurosci.
– volume: 81
  start-page: 917
  year: 1995
  end-page: 924
  ident: bb0235
  article-title: Crystal structure of the cys2 activator-binding domain of protein kinase C delta in complex with phorbol ester
  publication-title: Cell
– volume: 337
  start-page: 363
  year: 1999
  end-page: 371
  ident: bb0100
  article-title: Differential expression of two novel Munc13 proteins in rat brain
  publication-title: Biochem. J.
– volume: 99
  start-page: 9037
  year: 2002
  end-page: 9042
  ident: bb0130
  article-title: Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 270
  start-page: 10777
  year: 1995
  end-page: 10783
  ident: bb0220
  article-title: Characterization of the cysteine-rich region of the
  publication-title: J. Biol. Chem.
– volume: 279
  start-page: 27841
  year: 2004
  end-page: 27844
  ident: bb0155
  article-title: Munc13-1-mediated vesicle priming contributes to secretory amyloid precursor protein processing
  publication-title: J. Biol. Chem.
– volume: 281
  start-page: 19720
  year: 2006
  end-page: 19731
  ident: bb0210
  article-title: Binding to Rab3A-interacting molecule RIM regulates the presynaptic recruitment of Munc13-1 and ubMunc13-2
  publication-title: J. Biol. Chem.
– volume: 400
  start-page: 457
  year: 1999
  end-page: 461
  ident: bb0125
  article-title: Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles
  publication-title: Nature
– volume: 1215
  start-page: 9
  year: 2011
  end-page: 15
  ident: bb0365
  article-title: Bioavailability of resveratrol
  publication-title: Ann. N. Y. Acad. Sci.
– volume: 2
  start-page: 217
  year: 1988
  end-page: 221
  ident: bb0295
  article-title: Dynamic simulation as an essential tool in molecular modeling
  publication-title: J. Comput. Aided Mol. Des.
– volume: 14
  start-page: 27
  year: 2016
  ident: bb0390
  article-title: Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E
  publication-title: J. Nanobiotechnol.
– volume: 278
  start-page: 38970
  year: 2003
  end-page: 38979
  ident: bb0255
  article-title: Differential and regulated binding of cAMP-dependent protein kinase and protein kinase C isoenzymes to gravin in human model neurons: Evidence that gravin provides a dynamic platform for the localization for kinases during neuronal development
  publication-title: J. Biol. Chem.
– volume: 18
  start-page: 1463
  year: 1997
  end-page: 1472
  ident: bb0300
  article-title: LINCS: A linear constraint solver for molecular simulations
  publication-title: J. Comput. Chem.
– volume: 65
  year: 2012
  ident: bb0270
  article-title: Isolation and culture of hippocampal neurons from prenatal mice
  publication-title: J. Vis. Exp.
– volume: 12
  start-page: 491
  year: 2015
  end-page: 501
  ident: bb0380
  article-title: Diffusion efficiency and bioavailability of resveratrol administered to rat brain by different routes: therapeutic implications
  publication-title: Neurotherapeutics
– volume: 1215
  start-page: 103
  year: 2011
  end-page: 108
  ident: bb0015
  article-title: Neuroprotective properties of resveratrol and derivatives
  publication-title: Ann. N. Y. Acad. Sci.
– volume: 2
  start-page: 23
  year: 2007
  ident: bb0160
  article-title: Evidence against roles for phorbol binding protein Munc13-1, ADAM adaptor Eve-1, or vesicle trafficking phosphoproteins Munc18 or NSF as phospho-state-sensitive modulators of phorbol/PKC-activated Alzheimer APP ectodomain shedding
  publication-title: Mol. Neurodegener.
– volume: 126
  start-page: 715
  year: 2013
  end-page: 726
  ident: bb0245
  article-title: The pre-synaptic Munc13-1 binds alcohol and modulates alcohol self-administration in Drosophila
  publication-title: J. Neurochem.
– volume: 272
  start-page: 16081
  year: 1997
  end-page: 16084
  ident: bb0315
  article-title: Physical and functional interactions of Doc2 and Munc13 in Ca
  publication-title: J. Biol. Chem.
– volume: 33
  start-page: 8336
  year: 2013
  end-page: 8351
  ident: bb0095
  article-title: The Munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse
  publication-title: J. Neurosci.
– volume: 2
  start-page: 959
  year: 1999
  end-page: 964
  ident: bb0140
  article-title: UNC-13 is required for synaptic vesicle fusion in
  publication-title: Nat. Neurosci.
– volume: 837042
  year: 2015
  ident: bb0370
  article-title: Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans
  publication-title: Oxidative Med. Cell. Longev.
– volume: 55
  start-page: 6327
  year: 2016
  end-page: 6336
  ident: bb0260
  article-title: Curcumin inhibits protein kinase calpha activity by binding to its C1 domain
  publication-title: Biochemistry
– volume: 31
  start-page: 36
  year: 2013
  end-page: 45
  ident: bb0165
  article-title: Munc13 genotype regulates secretory amyloid precursor protein processing via postsynaptic glutamate receptors
  publication-title: Int. J. Dev. Neurosci.
– volume: 1290
  start-page: 107
  year: 2013
  end-page: 112
  ident: bb0385
  article-title: Nano-and micro-encapsulated systems for enhancing the delivery of resveratrol
  publication-title: Ann. N. Y. Acad. Sci.
– volume: 1852
  start-page: 1114
  year: 2015
  end-page: 1123
  ident: bb0035
  article-title: The molecular targets of resveratrol
  publication-title: Biochim. Biophys. Acta
– volume: 5
  start-page: 367
  year: 2012
  ident: bb0290
  article-title: ACPYPE - AnteChamber PYthon Parser interfacE
  publication-title: BMC Res. Notes
– volume: 114
  start-page: 12108
  year: 2014
  end-page: 12131
  ident: bb0215
  article-title: C1 domains: structure and ligand-binding properties
  publication-title: Chem. Rev.
– volume: 1852
  start-page: 1195
  year: 2015
  end-page: 1201
  ident: bb0335
  article-title: Neuroprotective action of resveratrol
  publication-title: Biochim. Biophys. Acta
– volume: 1637
  start-page: 59
  year: 2003
  end-page: 69
  ident: bb0065
  article-title: Inhibition of protein kinase C by resveratrol
  publication-title: Biochim. Biophys. Acta
– volume: 140
  start-page: 2187
  year: 2010
  end-page: 2192
  ident: bb0375
  article-title: Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells
  publication-title: J. Nutr.
– volume: 421
  start-page: 405
  year: 2009
  end-page: 413
  ident: bb0275
  article-title: PKC epsilon has an alcohol-binding site in its second cysteine-rich regulatory domain
  publication-title: Biochem. J.
– volume: 19
  start-page: 5321
  year: 2011
  end-page: 5333
  ident: bb0060
  article-title: Chemical modifications of resveratrol for improved protein kinase C alpha activity
  publication-title: Bioorg. Med. Chem.
– volume: 10
  start-page: 303
  year: 2000
  end-page: 311
  ident: bb0090
  article-title: Regulation of transmitter release by Unc-13 and its homologues
  publication-title: Curr. Opin. Neurobiol.
– volume: 272
  start-page: 2520
  year: 1997
  end-page: 2526
  ident: bb0075
  article-title: Direct interaction of the rat unc-13 homologue Munc13-1 with the N terminus of syntaxin
  publication-title: J. Biol. Chem.
– volume: 1850
  start-page: 2368
  year: 2015
  end-page: 2376
  ident: bb0250
  article-title: Alcohol binding in the C1 (C1A
  publication-title: Biochim. Biophys. Acta
– volume: 7
  year: 2012
  ident: bb0070
  article-title: PKC activation by resveratrol derivatives with unsaturated aliphatic chain
  publication-title: PLoS One
– volume: 9
  start-page: 779
  year: 2010
  end-page: 790
  ident: bb0170
  article-title: Genetic determinants of amyotrophic lateral sclerosis as therapeutic targets
  publication-title: CNS Neurol. Disord. Drug Targets
– volume: 44
  start-page: 1089
  year: 2005
  end-page: 1096
  ident: bb0230
  article-title: Intramolecular occlusion of the diacylglycerol-binding site in the C1 domain of munc13-1
  publication-title: Biochemistry
– volume: 6
  start-page: 218
  year: 2014
  ident: bb0020
  article-title: Neuroprotective effects of resveratrol in Alzheimer disease pathology
  publication-title: Front. Aging Neurosci.
– volume: 2015
  start-page: 392169
  year: 2015
  ident: bb0030
  article-title: Resveratrol: a focus on several neurodegenerative diseases
  publication-title: Oxidative Med. Cell. Longev.
– volume: 6
  start-page: 7319
  year: 2015
  ident: bb0195
  article-title: Neurodegeneration in
  publication-title: Nat. Commun.
– volume: 2
  start-page: 965
  year: 1999
  end-page: 971
  ident: bb0135
  article-title: UNC-13 is essential for synaptic transmission
  publication-title: Nat. Neurosci.
– volume: 41
  start-page: 375
  year: 2010
  end-page: 383
  ident: bb0025
  article-title: Resveratrol as a therapeutic agent for neurodegenerative diseases
  publication-title: Mol. Neurobiol.
– volume: 33
  start-page: 630.e3
  year: 2012
  end-page: 630.e8
  ident: bb0190
  article-title: UNC13A is a modifier of survival in amyotrophic lateral sclerosis
  publication-title: Neurobiol. Aging
– volume: 6
  start-page: 70
  year: 2009
  end-page: 81
  ident: bb0330
  article-title: Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection
  publication-title: Curr. Neurovasc. Res.
– volume: 76
  start-page: 120
  year: 2014
  end-page: 133
  ident: bb0185
  article-title: C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis
  publication-title: Ann. Neurol.
– volume: 19
  start-page: 4772
  year: 1999
  end-page: 4777
  ident: bb0080
  article-title: Regulation of the UNC-18-
  publication-title: J. Neurosci.
– volume: 1852
  start-page: 1114
  year: 2015
  ident: 10.1016/j.bbagen.2017.07.006_bb0035
  article-title: The molecular targets of resveratrol
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbadis.2014.10.005
– volume: 2
  start-page: 965
  year: 1999
  ident: 10.1016/j.bbagen.2017.07.006_bb0135
  article-title: Drosophila UNC-13 is essential for synaptic transmission
  publication-title: Nat. Neurosci.
  doi: 10.1038/14764
– volume: 81
  start-page: 917
  year: 1995
  ident: 10.1016/j.bbagen.2017.07.006_bb0235
  article-title: Crystal structure of the cys2 activator-binding domain of protein kinase C delta in complex with phorbol ester
  publication-title: Cell
  doi: 10.1016/0092-8674(95)90011-X
– volume: 55
  start-page: 6327
  year: 2016
  ident: 10.1016/j.bbagen.2017.07.006_bb0260
  article-title: Curcumin inhibits protein kinase calpha activity by binding to its C1 domain
  publication-title: Biochemistry
  doi: 10.1021/acs.biochem.6b00932
– volume: 65
  start-page: 712
  year: 2006
  ident: 10.1016/j.bbagen.2017.07.006_bb0285
  article-title: Comparison of multiple amber force fields and development of improved protein backbone parameters
  publication-title: Proteins
  doi: 10.1002/prot.21123
– volume: 2
  start-page: 959
  year: 1999
  ident: 10.1016/j.bbagen.2017.07.006_bb0140
  article-title: UNC-13 is required for synaptic vesicle fusion in C. elegans
  publication-title: Nat. Neurosci.
  doi: 10.1038/12160
– volume: 53
  start-page: S7
  year: 2009
  ident: 10.1016/j.bbagen.2017.07.006_bb0360
  article-title: Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
  publication-title: Mol. Nutr. Food Res.
  doi: 10.1002/mnfr.200800177
– volume: 6
  year: 2017
  ident: 10.1016/j.bbagen.2017.07.006_bb0325
  article-title: Mechanistic insights into neurotransmitter release and presynaptic plasticity from the crystal structure of Munc13-1 C1C2BMUN
  publication-title: elife
  doi: 10.7554/eLife.22567
– volume: 12
  start-page: 1017
  year: 2005
  ident: 10.1016/j.bbagen.2017.07.006_bb0205
  article-title: A minimal domain responsible for Munc13 activity
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/nsmb1001
– volume: 41
  start-page: 375
  year: 2010
  ident: 10.1016/j.bbagen.2017.07.006_bb0025
  article-title: Resveratrol as a therapeutic agent for neurodegenerative diseases
  publication-title: Mol. Neurobiol.
  doi: 10.1007/s12035-010-8111-y
– volume: 33
  start-page: 630.e3
  year: 2012
  ident: 10.1016/j.bbagen.2017.07.006_bb0190
  article-title: UNC13A is a modifier of survival in amyotrophic lateral sclerosis
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2011.10.029
– volume: 10
  start-page: 303
  year: 2000
  ident: 10.1016/j.bbagen.2017.07.006_bb0090
  article-title: Regulation of transmitter release by Unc-13 and its homologues
  publication-title: Curr. Opin. Neurobiol.
  doi: 10.1016/S0959-4388(00)00105-7
– volume: 7
  year: 2012
  ident: 10.1016/j.bbagen.2017.07.006_bb0070
  article-title: PKC activation by resveratrol derivatives with unsaturated aliphatic chain
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0052888
– volume: 1850
  start-page: 2368
  year: 2015
  ident: 10.1016/j.bbagen.2017.07.006_bb0250
  article-title: Alcohol binding in the C1 (C1A+C1B) domain of protein kinase C epsilon
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbagen.2015.07.005
– volume: 6
  start-page: 70
  year: 2009
  ident: 10.1016/j.bbagen.2017.07.006_bb0330
  article-title: Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection
  publication-title: Curr. Neurovasc. Res.
  doi: 10.2174/156720209787466019
– volume: 1215
  start-page: 72
  year: 2011
  ident: 10.1016/j.bbagen.2017.07.006_bb0340
  article-title: Resveratrol modulates astroglial functions: neuroprotective hypothesis
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/j.1749-6632.2010.05857.x
– volume: 5
  start-page: 367
  year: 2012
  ident: 10.1016/j.bbagen.2017.07.006_bb0290
  article-title: ACPYPE - AnteChamber PYthon Parser interfacE
  publication-title: BMC Res. Notes
  doi: 10.1186/1756-0500-5-367
– volume: 2015
  start-page: 392169
  year: 2015
  ident: 10.1016/j.bbagen.2017.07.006_bb0030
  article-title: Resveratrol: a focus on several neurodegenerative diseases
  publication-title: Oxidative Med. Cell. Longev.
  doi: 10.1155/2015/392169
– volume: 55
  start-page: 1421
  year: 2006
  ident: 10.1016/j.bbagen.2017.07.006_bb0120
  article-title: Munc13-1 deficiency reduces insulin secretion and causes abnormal glucose tolerance
  publication-title: Diabetes
  doi: 10.2337/db05-1263
– volume: 4
  start-page: 435
  year: 2008
  ident: 10.1016/j.bbagen.2017.07.006_bb0280
  article-title: GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation
  publication-title: J. Chem. Theory Comput.
  doi: 10.1021/ct700301q
– year: 2017
  ident: 10.1016/j.bbagen.2017.07.006_bb0145
  article-title: Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI90259
– volume: 270
  start-page: 10777
  year: 1995
  ident: 10.1016/j.bbagen.2017.07.006_bb0220
  article-title: Characterization of the cysteine-rich region of the Caenorhabditis elegans protein Unc-13 as a high affinity phorbol ester receptor. Analysis of ligand-binding interactions, lipid cofactor requirements, and inhibitor sensitivity
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.270.18.10777
– volume: 421
  start-page: 405
  year: 2009
  ident: 10.1016/j.bbagen.2017.07.006_bb0275
  article-title: PKC epsilon has an alcohol-binding site in its second cysteine-rich regulatory domain
  publication-title: Biochem. J.
  doi: 10.1042/BJ20082271
– volume: 44
  start-page: 1089
  year: 2005
  ident: 10.1016/j.bbagen.2017.07.006_bb0230
  article-title: Intramolecular occlusion of the diacylglycerol-binding site in the C1 domain of munc13-1
  publication-title: Biochemistry
  doi: 10.1021/bi0476127
– volume: 6
  start-page: 218
  year: 2014
  ident: 10.1016/j.bbagen.2017.07.006_bb0020
  article-title: Neuroprotective effects of resveratrol in Alzheimer disease pathology
  publication-title: Front. Aging Neurosci.
  doi: 10.3389/fnagi.2014.00218
– volume: 57
  start-page: 103
  year: 2014
  ident: 10.1016/j.bbagen.2017.07.006_bb0180
  article-title: Recent progress in the genetics of motor neuron disease
  publication-title: Eur. J. Med. Genet.
  doi: 10.1016/j.ejmg.2014.01.002
– volume: 1637
  start-page: 59
  year: 2003
  ident: 10.1016/j.bbagen.2017.07.006_bb0065
  article-title: Inhibition of protein kinase C by resveratrol
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/S0925-4439(02)00214-4
– volume: 19
  start-page: 4772
  year: 1999
  ident: 10.1016/j.bbagen.2017.07.006_bb0080
  article-title: Regulation of the UNC-18-Caenorhabditis elegans syntaxin complex by UNC-13
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.19-12-04772.1999
– volume: 79
  start-page: 82
  year: 2013
  ident: 10.1016/j.bbagen.2017.07.006_bb0110
  article-title: Dynamic control of synaptic vesicle replenishment and short-term plasticity by Ca(2+)-calmodulin-Munc13-1 signaling
  publication-title: Neuron
  doi: 10.1016/j.neuron.2013.05.011
– volume: 1348
  start-page: 124
  year: 2015
  ident: 10.1016/j.bbagen.2017.07.006_bb0045
  article-title: Direct molecular targets of resveratrol: identifying key interactions to unlock complex mechanisms
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/nyas.12796
– volume: 279
  start-page: 27841
  year: 2004
  ident: 10.1016/j.bbagen.2017.07.006_bb0155
  article-title: Munc13-1-mediated vesicle priming contributes to secretory amyloid precursor protein processing
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.C400122200
– volume: 65
  year: 2012
  ident: 10.1016/j.bbagen.2017.07.006_bb0270
  article-title: Isolation and culture of hippocampal neurons from prenatal mice
  publication-title: J. Vis. Exp.
– volume: 23
  start-page: 131
  year: 1998
  ident: 10.1016/j.bbagen.2017.07.006_bb0345
  article-title: Adverse psychological impact, glutamatergic dysfunction, and risk factors for Alzheimer's disease
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/S0149-7634(98)00039-6
– volume: 19
  start-page: 5321
  year: 2011
  ident: 10.1016/j.bbagen.2017.07.006_bb0060
  article-title: Chemical modifications of resveratrol for improved protein kinase C alpha activity
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2011.08.008
– volume: 114
  start-page: 12108
  year: 2014
  ident: 10.1016/j.bbagen.2017.07.006_bb0215
  article-title: C1 domains: structure and ligand-binding properties
  publication-title: Chem. Rev.
  doi: 10.1021/cr300481j
– volume: 17
  start-page: 1975
  year: 2003
  ident: 10.1016/j.bbagen.2017.07.006_bb0005
  article-title: Resveratrol: from grapevines to mammalian biology
  publication-title: FASEB J.
  doi: 10.1096/fj.03-0168rev
– volume: 1215
  start-page: 103
  year: 2011
  ident: 10.1016/j.bbagen.2017.07.006_bb0015
  article-title: Neuroprotective properties of resveratrol and derivatives
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/j.1749-6632.2010.05865.x
– volume: 1
  start-page: 2406
  year: 2006
  ident: 10.1016/j.bbagen.2017.07.006_bb0265
  article-title: Culturing hippocampal neurons
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2006.356
– volume: 337
  start-page: 363
  year: 1999
  ident: 10.1016/j.bbagen.2017.07.006_bb0100
  article-title: Differential expression of two novel Munc13 proteins in rat brain
  publication-title: Biochem. J.
  doi: 10.1042/bj3370363
– volume: 6
  start-page: 7319
  year: 2015
  ident: 10.1016/j.bbagen.2017.07.006_bb0195
  article-title: Neurodegeneration in C. elegans models of ALS requires TIR-1/Sarm1 immune pathway activation in neurons
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms8319
– volume: 14
  start-page: 27
  year: 2016
  ident: 10.1016/j.bbagen.2017.07.006_bb0390
  article-title: Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E
  publication-title: J. Nanobiotechnol.
  doi: 10.1186/s12951-016-0177-x
– volume: 2
  start-page: 217
  year: 1988
  ident: 10.1016/j.bbagen.2017.07.006_bb0295
  article-title: Dynamic simulation as an essential tool in molecular modeling
  publication-title: J. Comput. Aided Mol. Des.
  doi: 10.1007/BF01531994
– volume: 1215
  start-page: 9
  year: 2011
  ident: 10.1016/j.bbagen.2017.07.006_bb0365
  article-title: Bioavailability of resveratrol
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/j.1749-6632.2010.05842.x
– volume: 33
  start-page: 8336
  year: 2013
  ident: 10.1016/j.bbagen.2017.07.006_bb0095
  article-title: The Munc13 proteins differentially regulate readily releasable pool dynamics and calcium-dependent recovery at a central synapse
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.5128-12.2013
– volume: 9
  start-page: 779
  year: 2010
  ident: 10.1016/j.bbagen.2017.07.006_bb0170
  article-title: Genetic determinants of amyotrophic lateral sclerosis as therapeutic targets
  publication-title: CNS Neurol. Disord. Drug Targets
  doi: 10.2174/187152710793237494
– volume: 20
  start-page: 666
  year: 2000
  ident: 10.1016/j.bbagen.2017.07.006_bb0355
  article-title: SNARE protein-dependent glutamate release from astrocytes
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.20-02-00666.2000
– volume: 837042
  year: 2015
  ident: 10.1016/j.bbagen.2017.07.006_bb0370
  article-title: Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans
  publication-title: Oxidative Med. Cell. Longev.
– volume: 49
  start-page: 786
  year: 2014
  ident: 10.1016/j.bbagen.2017.07.006_bb0175
  article-title: Genetic heterogeneity of amyotrophic lateral sclerosis: implications for clinical practice and research
  publication-title: Muscle Nerve
  doi: 10.1002/mus.24198
– volume: 400
  start-page: 457
  year: 1999
  ident: 10.1016/j.bbagen.2017.07.006_bb0125
  article-title: Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles
  publication-title: Nature
  doi: 10.1038/22768
– volume: 272
  start-page: 2520
  year: 1997
  ident: 10.1016/j.bbagen.2017.07.006_bb0075
  article-title: Direct interaction of the rat unc-13 homologue Munc13-1 with the N terminus of syntaxin
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.272.4.2520
– volume: 31
  start-page: 12053
  year: 2011
  ident: 10.1016/j.bbagen.2017.07.006_bb0115
  article-title: Munc13-1 is required for presynaptic long-term potentiation
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.2276-11.2011
– volume: 103
  start-page: 8577
  year: 1995
  ident: 10.1016/j.bbagen.2017.07.006_bb0305
  article-title: A Smooth particle mesh ewald method
  publication-title: J. Chem. Phys.
  doi: 10.1063/1.470117
– volume: 60
  start-page: 323
  year: 2008
  ident: 10.1016/j.bbagen.2017.07.006_bb0055
  article-title: Resveratrol: one molecule, many targets
  publication-title: IUBMB Life
  doi: 10.1002/iub.47
– volume: 42
  start-page: S177
  year: 2014
  ident: 10.1016/j.bbagen.2017.07.006_bb0350
  article-title: Glutamatergic dysfunctioning in Alzheimer's disease and related therapeutic targets
  publication-title: J. Alzheimers Dis.
  doi: 10.3233/JAD-132621
– volume: 33
  start-page: 411
  year: 2002
  ident: 10.1016/j.bbagen.2017.07.006_bb0105
  article-title: Differential control of vesicle priming and short-term plasticity by Munc13 isoforms
  publication-title: Neuron
  doi: 10.1016/S0896-6273(02)00568-8
– volume: 126
  start-page: 715
  year: 2013
  ident: 10.1016/j.bbagen.2017.07.006_bb0245
  article-title: The pre-synaptic Munc13-1 binds alcohol and modulates alcohol self-administration in Drosophila
  publication-title: J. Neurochem.
  doi: 10.1111/jnc.12315
– volume: 76
  start-page: 120
  year: 2014
  ident: 10.1016/j.bbagen.2017.07.006_bb0185
  article-title: C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.24198
– volume: 18
  start-page: 1463
  year: 1997
  ident: 10.1016/j.bbagen.2017.07.006_bb0300
  article-title: LINCS: A linear constraint solver for molecular simulations
  publication-title: J. Comput. Chem.
  doi: 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
– volume: 2
  start-page: 23
  year: 2007
  ident: 10.1016/j.bbagen.2017.07.006_bb0160
  article-title: Evidence against roles for phorbol binding protein Munc13-1, ADAM adaptor Eve-1, or vesicle trafficking phosphoproteins Munc18 or NSF as phospho-state-sensitive modulators of phorbol/PKC-activated Alzheimer APP ectodomain shedding
  publication-title: Mol. Neurodegener.
  doi: 10.1186/1750-1326-2-23
– volume: 272
  start-page: 16081
  year: 1997
  ident: 10.1016/j.bbagen.2017.07.006_bb0315
  article-title: Physical and functional interactions of Doc2 and Munc13 in Ca2+-dependent exocytotic machinery
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.272.26.16081
– volume: 50
  start-page: 431
  year: 2002
  ident: 10.1016/j.bbagen.2017.07.006_bb0010
  article-title: An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine
  publication-title: J. Agric. Food Chem.
  doi: 10.1021/jf010812u
– volume: 55
  start-page: 2135
  year: 2016
  ident: 10.1016/j.bbagen.2017.07.006_bb0240
  article-title: Selective modulation of protein kinase C alpha over protein kinase C epsilon by curcumin and its derivatives in CHO-K1 Cells
  publication-title: Biochemistry
  doi: 10.1021/acs.biochem.6b00057
– volume: 4
  start-page: 119
  year: 2013
  ident: 10.1016/j.bbagen.2017.07.006_bb0320
  article-title: Munc13-1 translocates to the plasma membrane in a Doc2B- and calcium-dependent manner
  publication-title: Front. Endocrinol.
  doi: 10.3389/fendo.2013.00119
– volume: 64
  start-page: 759
  year: 2003
  ident: 10.1016/j.bbagen.2017.07.006_bb0310
  article-title: Stilbenes from the roots of Pleuropterus ciliinervis and their antioxidant activities
  publication-title: Phytochemistry
  doi: 10.1016/S0031-9422(03)00417-5
– volume: 18
  start-page: 542
  year: 2011
  ident: 10.1016/j.bbagen.2017.07.006_bb0200
  article-title: Munc13 mediates the transition from the closed syntaxin-Munc18 complex to the SNARE complex
  publication-title: Nat. Struct. Mol. Biol.
  doi: 10.1038/nsmb.2047
– volume: 278
  start-page: 38970
  year: 2003
  ident: 10.1016/j.bbagen.2017.07.006_bb0255
  article-title: Differential and regulated binding of cAMP-dependent protein kinase and protein kinase C isoenzymes to gravin in human model neurons: Evidence that gravin provides a dynamic platform for the localization for kinases during neuronal development
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M306749200
– volume: 31
  start-page: 36
  year: 2013
  ident: 10.1016/j.bbagen.2017.07.006_bb0165
  article-title: Munc13 genotype regulates secretory amyloid precursor protein processing via postsynaptic glutamate receptors
  publication-title: Int. J. Dev. Neurosci.
  doi: 10.1016/j.ijdevneu.2012.10.001
– volume: 99
  start-page: 9037
  year: 2002
  ident: 10.1016/j.bbagen.2017.07.006_bb0130
  article-title: Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.122623799
– volume: 281
  start-page: 19720
  year: 2006
  ident: 10.1016/j.bbagen.2017.07.006_bb0210
  article-title: Binding to Rab3A-interacting molecule RIM regulates the presynaptic recruitment of Munc13-1 and ubMunc13-2
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M601421200
– volume: 27
  start-page: 1200
  year: 2007
  ident: 10.1016/j.bbagen.2017.07.006_bb0225
  article-title: Munc13-1 C1 domain activation lowers the energy barrier for synaptic vesicle fusion
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.4908-06.2007
– volume: 11
  start-page: 2851
  year: 2009
  ident: 10.1016/j.bbagen.2017.07.006_bb0050
  article-title: Resveratrol: its biologic targets and functional activity
  publication-title: Antioxid. Redox Signal.
  doi: 10.1089/ars.2008.2412
– volume: 140
  start-page: 2187
  year: 2010
  ident: 10.1016/j.bbagen.2017.07.006_bb0375
  article-title: Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells
  publication-title: J. Nutr.
  doi: 10.3945/jn.110.123505
– volume: 21
  start-page: 123
  year: 1998
  ident: 10.1016/j.bbagen.2017.07.006_bb0085
  article-title: Munc13-1 is a presynaptic phorbol ester receptor that enhances neurotransmitter release
  publication-title: Neuron
  doi: 10.1016/S0896-6273(00)80520-6
– volume: 60
  start-page: 323
  year: 2008
  ident: 10.1016/j.bbagen.2017.07.006_bb0040
  article-title: Resveratrol: one molecule, many targets
  publication-title: IUBMB Life
  doi: 10.1002/iub.47
– volume: 1852
  start-page: 1195
  year: 2015
  ident: 10.1016/j.bbagen.2017.07.006_bb0335
  article-title: Neuroprotective action of resveratrol
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbadis.2014.09.011
– volume: 22
  start-page: 467
  year: 2004
  ident: 10.1016/j.bbagen.2017.07.006_bb0150
  article-title: New players in old amyloid precursor protein-processing pathways
  publication-title: Int. J. Dev. Neurosci.
  doi: 10.1016/j.ijdevneu.2004.07.004
– volume: 12
  start-page: 491
  year: 2015
  ident: 10.1016/j.bbagen.2017.07.006_bb0380
  article-title: Diffusion efficiency and bioavailability of resveratrol administered to rat brain by different routes: therapeutic implications
  publication-title: Neurotherapeutics
  doi: 10.1007/s13311-014-0334-6
– volume: 1290
  start-page: 107
  year: 2013
  ident: 10.1016/j.bbagen.2017.07.006_bb0385
  article-title: Nano-and micro-encapsulated systems for enhancing the delivery of resveratrol
  publication-title: Ann. N. Y. Acad. Sci.
  doi: 10.1111/nyas.12130
– reference: 11804508 - J Agric Food Chem. 2002 Jan 30;50(3):431-5
– reference: 18421779 - IUBMB Life. 2008 May;60(5):323-32
– reference: 16644700 - Diabetes. 2006 May;55(5):1421-9
– reference: 16228007 - Nat Struct Mol Biol. 2005 Nov;12(11):1017-8
– reference: 26059317 - Nat Commun. 2015 Jun 10;6:7319
– reference: 10851170 - Curr Opin Neurobiol. 2000 Jun;10(3):303-11
– reference: 24931836 - Ann Neurol. 2014 Jul;76(1):120-33
– reference: 14597667 - FASEB J. 2003 Nov;17(14):1975-85
– reference: 21880495 - Bioorg Med Chem. 2011 Sep 15;19(18):5321-33
– reference: 19194969 - Mol Nutr Food Res. 2009 May;53 Suppl 1:S7-15
– reference: 17267576 - J Neurosci. 2007 Jan 31;27(5):1200-10
– reference: 10526333 - Nat Neurosci. 1999 Nov;2(11):959-64
– reference: 24670398 - J Alzheimers Dis. 2014;42 Suppl 3:S177-87
– reference: 27061902 - J Nanobiotechnology. 2016 Apr 09;14 :27
– reference: 18067682 - Mol Neurodegener. 2007 Dec 09;2:23
– reference: 15123597 - J Biol Chem. 2004 Jul 2;279(27):27841-4
– reference: 23692447 - J Neurochem. 2013 Sep;126(6):715-26
– reference: 21849565 - J Neurosci. 2011 Aug 17;31(33):12053-7
– reference: 22824207 - BMC Res Notes. 2012 Jul 23;5:367
– reference: 21261643 - Ann N Y Acad Sci. 2011 Jan;1215:72-8
– reference: 19355928 - Curr Neurovasc Res. 2009 Feb;6(1):70-81
– reference: 12070347 - Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):9037-42
– reference: 23658173 - J Neurosci. 2013 May 8;33(19):8336-51
– reference: 20942785 - CNS Neurol Disord Drug Targets. 2010 Dec;9(6):779-90
– reference: 21261647 - Ann N Y Acad Sci. 2011 Jan;1215:103-8
– reference: 17406484 - Nat Protoc. 2006;1(5):2406-15
– reference: 20306310 - Mol Neurobiol. 2010 Jun;41(2-3):375-83
– reference: 15667202 - Biochemistry. 2005 Feb 1;44(4):1089-96
– reference: 27776404 - Biochemistry. 2016 Nov 15;55(45):6327-6336
– reference: 9195900 - J Biol Chem. 1997 Jun 27;272(26):16081-4
– reference: 12857743 - J Biol Chem. 2003 Oct 3;278(40):38970-9
– reference: 22871921 - J Vis Exp. 2012 Jul 26;(65):null
– reference: 10440375 - Nature. 1999 Jul 29;400(6743):457-61
– reference: 21499244 - Nat Struct Mol Biol. 2011 May;18(5):542-9
– reference: 28192369 - J Clin Invest. 2017 Mar 1;127(3):1005-1018
– reference: 10526334 - Nat Neurosci. 1999 Nov;2(11):965-71
– reference: 25281824 - Biochim Biophys Acta. 2015 Jun;1852(6):1195-201
– reference: 26180587 - Oxid Med Cell Longev. 2015;2015:392169
– reference: 24488689 - Muscle Nerve. 2014 Jun;49(6):786-803
– reference: 24062723 - Front Endocrinol (Lausanne). 2013 Sep 17;4:119
– reference: 11832228 - Neuron. 2002 Jan 31;33(3):411-24
– reference: 21261636 - Ann N Y Acad Sci. 2011 Jan;1215:9-15
– reference: 23285216 - PLoS One. 2012;7(12):e52888
– reference: 23855472 - Ann N Y Acad Sci. 2013 Jul;1290:107-12
– reference: 13679099 - Phytochemistry. 2003 Oct;64(3):759-63
– reference: 7537738 - J Biol Chem. 1995 May 5;270(18):10777-83
– reference: 10632596 - J Neurosci. 2000 Jan 15;20(2):666-73
– reference: 26983836 - Biochemistry. 2016 Apr 12;55(14):2135-43
– reference: 19432534 - Antioxid Redox Signal. 2009 Nov;11(11):2851-97
– reference: 25588581 - Neurotherapeutics. 2015 Apr;12(2):491-501
– reference: 25309423 - Front Aging Neurosci. 2014 Sep 11;6:218
– reference: 9697857 - Neuron. 1998 Jul;21(1):123-36
– reference: 10366611 - J Neurosci. 1999 Jun 15;19(12):4772-7
– reference: 24503148 - Eur J Med Genet. 2014 Feb;57(2-3):103-12
– reference: 26210390 - Biochim Biophys Acta. 2015 Nov;1850(11):2368-76
– reference: 16981200 - Proteins. 2006 Nov 15;65(3):712-25
– reference: 8999968 - J Biol Chem. 1997 Jan 24;272(4):2520-6
– reference: 26221416 - Oxid Med Cell Longev. 2015;2015:837042
– reference: 16704978 - J Biol Chem. 2006 Jul 14;281(28):19720-31
– reference: 28177287 - Elife. 2017 Feb 08;6:null
– reference: 9861617 - Neurosci Biobehav Rev. 1998;23(1):131-9
– reference: 7781068 - Cell. 1995 Jun 16;81(6):917-24
– reference: 19432558 - Biochem J. 2009 Jul 15;421(3):405-13
– reference: 20980646 - J Nutr. 2010 Dec;140(12):2187-92
– reference: 22118904 - Neurobiol Aging. 2012 Mar;33(3):630.e3-8
– reference: 23070049 - Int J Dev Neurosci. 2013 Feb;31(1):36-45
– reference: 26620784 - J Chem Theory Comput. 2008 Mar;4(3):435-47
– reference: 25315298 - Biochim Biophys Acta. 2015 Jun;1852(6):1114-23
– reference: 25375355 - Chem Rev. 2014 Dec 24;114(24):12108-31
– reference: 15465276 - Int J Dev Neurosci. 2004 Nov;22(7):467-74
– reference: 12527408 - Biochim Biophys Acta. 2003 Jan 20;1637(1):59-69
– reference: 26099829 - Ann N Y Acad Sci. 2015 Aug;1348(1):124-33
– reference: 9895278 - Biochem J. 1999 Feb 1;337 ( Pt 3):363-71
– reference: 3236048 - J Comput Aided Mol Des. 1988 Oct;2(3):217-21
– reference: 23770256 - Neuron. 2013 Jul 10;79(1):82-96
SSID ssj0000595
ssj0025309
Score 2.2732618
Snippet Resveratrol (1) is a naturally occurring polyphenol that has been implicated in neuroprotection. One of resveratrol's several biological targets is...
Resveratrol (1) is a naturally occurring polyphenol that has been implicated in neuroprotection. One of resveratrol's several biological targets is Ca...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2640
SubjectTerms Activation
Animals
Binding Sites
confocal microscopy
cytosol
Free Radical Scavengers - administration & dosage
Free Radical Scavengers - chemistry
Hippocampus - drug effects
Hippocampus - metabolism
Humans
Inhibition
Membrane translocation
Mice
Molecular Docking Simulation
molecular models
Munc13-1
mutants
Nerve Tissue Proteins - antagonists & inhibitors
Nerve Tissue Proteins - chemistry
Nerve Tissue Proteins - metabolism
neurodegenerative diseases
neurons
Neurons - drug effects
Neurons - metabolism
Neuroprotection
neuroprotective effect
neurotransmitters
Phorbol Esters - administration & dosage
Phorbol Esters - chemistry
plasma membrane
Polyphenol
polyphenols
Presynaptic
Primary Cell Culture
Protein kinase C
Protein Kinase C-alpha - antagonists & inhibitors
Protein Kinase C-alpha - chemistry
Resveratrol
SNARE Proteins - chemistry
SNARE Proteins - metabolism
Stilbenes - administration & dosage
Synaptic Transmission - drug effects
Title Resveratrol inhibits phorbol ester-induced membrane translocation of presynaptic Munc13-1
URI https://dx.doi.org/10.1016/j.bbagen.2017.07.006
https://www.ncbi.nlm.nih.gov/pubmed/28713022
https://www.proquest.com/docview/1920196394
https://www.proquest.com/docview/2000463394
https://pubmed.ncbi.nlm.nih.gov/PMC5623624
Volume 1861
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swELYQaIKXaWPA2BjyJF5Dk9hOmkdUgcoqeOCHgCfLjm01CJKqDZN44W_nzkk6ypiQ9lQ1uVSu7-L7Tnf3HSF7HDB8ZjTWPDkBAQrjQZ_pNLDGORslqYt9NeHJaTK85L-uxfUSGXS9MFhW2Z79zZnuT-v2Sq_dzd6kKHrnmNQDOCEiMFIA1tjEx3mKVr7_9KfMA-CDaDIJPEDprn3O13hpDS8tsqBGqafwxLlHb7unv-Hn6yrKF27p6BP52OJJetAs-TNZsuU6-dBMmHxcJ6uDbqDbF3JzZme_kUN5Wt3RohwXuqhndDKuphoueMaEACJ00LWh9_YewujS0hp9GTo8VCCtHMXC2cdSwUmT0xNwihEoYINcHh1eDIZBO1khyHmW1EHSj51QqXWpNkpoZwAnuH7IrFaZZkaxCO6b1AJ2EjoxMdPCuUT3QwUen1vFNslyWZX2K6H4CwpiSohuQ-5yo3KQysKcY148N2KbsG5DZd7SjuP0izvZ1ZfdykYNEtUgQ8yHJ9skmD81aWg33pFPO13JBfOR4BneefJnp1oJ-sB0Cexu9TCTgH2RPIhl_N8yse--ZV5mqzGH-XoxFgXLjGFtC4YyF0Bm78U7ZTH2DN8ISpOYf_vvf_WdrOG3pmlyhyzX0wf7A9BTrXf967FLVg6OR8NT_BydXY2eAcscHXo
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB2VIlQuqJSvQgEjcQ2bxHayOaIV1QLdHqCVysmyY1sb1Car3RSpF347M06ydAuoEtd4EjmeseeNZvwG4K1ADF9YQzVPXmKAwkU05iaPnPXeJVnu01BNODvOpqfi05k824LJcBeGyir7s78708Np3T8Z9as5WlTV6Csl9RBOyASNFIF1cQfuCty-1Mbg3c_fdR6IH2SXShARiQ_350KRlzG4a4kGNckDhyc1Pvq7f_oTf94so7zmlw534UEPKNn7bs4PYcvVe3CvazF5tQc7k6Gj2yP49sWtfhCJ8rI5Z1U9r0zVrthi3iwNPgiUCRGG6Khsyy7cBcbRtWMtOTPyeKRB1nhGlbNXtcajpmQz9IoJauAxnB5-OJlMo761QlSKImujbJx6qXPnc2O1NN4iUPDjmDujC8Ot5gmO29wheJImsyk30vvMjGONLl84zZ_Adt3U7hkw-oLGoBLD21j40uoSpYq4FJQYL63cBz4sqCp73nFqf3GuhgKz76pTgyI1qJgS4tk-ROu3Fh3vxi3y-aArtWE_Cl3DLW--GVSrUB-UL8HVbS5XCsEvsQfxQvxbJg3Xb3mQedqZw3q-FIyiaaY4tw1DWQsQtffmSF3NA8U3odIsFc__-69ew870ZHakjj4ef34B92mku0F5ANvt8tK9RCjVmldhq_wCL04dZQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Resveratrol+inhibits+phorbol+ester-induced+membrane+translocation+of+presynaptic+Munc13-1&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Pany%2C+Satyabrata&rft.au=Ghosh%2C+Anamitra&rft.au=You%2C+Youngki&rft.au=Nguy%E1%BB%85n%2C+Nga&rft.date=2017-11-01&rft.issn=0304-4165&rft.volume=1861&rft.issue=11+p.2640-2651&rft.spage=2640&rft.epage=2651&rft_id=info:doi/10.1016%2Fj.bbagen.2017.07.006&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon